Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
105last 24h
3124last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Investing.com117d agobearish
Biogen tumbles 8.7% as breakthrough Alzheimer’s data is clouded by dosing paradoxSimply Wall St.117d agoneutral
How Investors Are Reacting To Biogen (BIIB) At-Home LEQEMBI Autoinjector ApprovalInvestorsHub117d agoneutral
Biogen Shares Rise After Positive Phase 2 Alzheimer’s Trial Results (BIIB)Investing.com118d agobullish
Truist upgrades Biogen to Buy on Alzheimer’s, pipeline optimism ahead of key dataBarrons.com118d agobullish
Biogen Stock Is Upgraded to Buy Ahead of Key Alzheimer’s Drug Study DetailsBarrons.com118d agoneutral
Can Biogen Convince Skeptics That Cutting a Rogue Protein Slows Alzheimer’s?Simply Wall St.122d agoneutral
Will New Board Appointment And mRNA Flu Progress Change Moderna's (MRNA) Pipeline Diversification Narrative?BioPharma Dive124d agoneutral
Vertex to acquire Crinetics in $10B foray into endocrine disease drugsInsider Monkey126d agobullish
Here is Why Biogen (BIIB) is One of the Most Undervalued NASDAQ Stocks to Buy Right NowStocktwits129d agoneutral
BIIB Stock Ends 3% Higher - Why This Strategist Picks Biogen Over Other Biotech Peers